JP2013528570A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013528570A5 JP2013528570A5 JP2013502023A JP2013502023A JP2013528570A5 JP 2013528570 A5 JP2013528570 A5 JP 2013528570A5 JP 2013502023 A JP2013502023 A JP 2013502023A JP 2013502023 A JP2013502023 A JP 2013502023A JP 2013528570 A5 JP2013528570 A5 JP 2013528570A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- region
- groups
- moiety
- intact antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31931310P | 2010-03-31 | 2010-03-31 | |
| US61/319,313 | 2010-03-31 | ||
| PCT/IB2011/051373 WO2011121560A2 (en) | 2010-03-31 | 2011-03-31 | Stabilized antibody preparations and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013528570A JP2013528570A (ja) | 2013-07-11 |
| JP2013528570A5 true JP2013528570A5 (https=) | 2014-04-24 |
Family
ID=44543567
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013502023A Pending JP2013528570A (ja) | 2010-03-31 | 2011-03-31 | 安定化された抗体調製物およびその使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20130028920A1 (https=) |
| EP (1) | EP2552482A2 (https=) |
| JP (1) | JP2013528570A (https=) |
| CA (1) | CA2794631A1 (https=) |
| WO (1) | WO2011121560A2 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9155745B2 (en) | 2009-06-16 | 2015-10-13 | Universite De Geneve | Bevacizumab formulations with lower aggregation propensity, comprising corticosteroid anti-inflammatory drugs |
| JP2013523717A (ja) * | 2010-03-31 | 2013-06-17 | ユニベルシテ ドゥ ジュネーブ | 安定化された抗体調製物およびその使用 |
| US20130090375A1 (en) * | 2011-10-06 | 2013-04-11 | Cornell University | Virus-mediated delivery of bevacizumab for therapeutic applications |
| ES2874774T3 (es) | 2011-12-22 | 2021-11-05 | Geron Corp | Análogos de guanina como sustratos de telomerasa y afectores de la longitud de los telómeros |
| FR2995214B1 (fr) | 2012-09-10 | 2014-11-21 | Adocia | Solution a viscosite reduite de proteine a concentration elevee |
| IL312865B2 (en) | 2013-09-11 | 2025-06-01 | Eagle Biologics Inc | Liquid protein formulations containing viscosity-lowering agents |
| EP3200804A4 (en) | 2014-10-01 | 2018-04-18 | Eagle Biologics, Inc. | Polysaccharide and nucleic acid formulations containing viscosity-lowering agents |
| EP3617235B1 (en) * | 2017-04-28 | 2026-02-18 | Ajinomoto Co., Inc. | Compound having substance that has affinity for soluble protein, cleavable moiety, and reactive group, or salt thereof |
| CA3063324A1 (en) | 2017-05-16 | 2018-11-22 | Bhami's Research Laboratory, Pvt. Ltd. | High concentration protein formulations with reduced viscosity |
| US10768185B2 (en) | 2017-07-20 | 2020-09-08 | Trustees Of Boston University | Tenofovir detection assay |
| AU2019333047A1 (en) | 2018-08-30 | 2020-12-03 | Regeneron Pharmaceuticals, Inc. | Methods for characterizing protein complexes |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0018609B1 (de) | 1979-04-30 | 1983-09-21 | Hoechst Aktiengesellschaft | Gegen Denaturierung beständige, wässrige Protein-Lösungen, Verfahren zu ihrer Herstellung und ihre Verwendung |
| US4362661A (en) | 1979-08-09 | 1982-12-07 | Teijin Limited | Immunoglobulin composition having a high monomer content, and process for production thereof |
| AU3722984A (en) | 1984-01-05 | 1985-07-11 | Manlab Pty. Ltd. | Reagents for immunoassay at elevated temperatures |
| US4808705A (en) | 1986-12-19 | 1989-02-28 | Cetus Corporation | Stable formulations of ricin toxin a chain and of RTA-immunoconjugates and stabilizer screening methods therefor |
| EP1370292A1 (en) * | 2001-01-31 | 2003-12-17 | Idec Pharmaceuticals Corporation | Use of cd23 antagonists for the treatment of neoplastic disorders |
| AU2003219664A1 (en) * | 2002-01-16 | 2003-09-02 | Eliezer Rapaport | Methods and therapeutic compositions in the treatment of advanced cancer |
| CA2512174A1 (en) * | 2003-01-30 | 2004-08-12 | Christian B. Allan | Anti-integrin .alpha..nu..beta.3 antibody formulations and uses thereof |
| WO2004068115A2 (en) * | 2003-01-30 | 2004-08-12 | Bellbrook Labs, Llc | Assay method for group transfer reactions |
| EP1532983A1 (en) | 2003-11-18 | 2005-05-25 | ZLB Bioplasma AG | Immunoglobulin preparations having increased stability |
| KR20080019249A (ko) * | 2005-06-15 | 2008-03-03 | 쉐링 코포레이션 | 안정한 항체 제형 |
| US20080160019A1 (en) * | 2006-10-17 | 2008-07-03 | Dyax Corp. | Sequential combination therapy |
| KR20190140090A (ko) * | 2007-07-09 | 2019-12-18 | 제넨테크, 인크. | 폴리펩티드의 재조합 생산 동안의 디술피드 결합 환원의 방지 |
| WO2010132047A1 (en) * | 2009-05-14 | 2010-11-18 | Rensselaer Polytechnic Institute | Guanosine/gmp gels and uses thereof |
| JP2013523717A (ja) * | 2010-03-31 | 2013-06-17 | ユニベルシテ ドゥ ジュネーブ | 安定化された抗体調製物およびその使用 |
-
2011
- 2011-03-31 CA CA2794631A patent/CA2794631A1/en not_active Abandoned
- 2011-03-31 JP JP2013502023A patent/JP2013528570A/ja active Pending
- 2011-03-31 EP EP11715612A patent/EP2552482A2/en not_active Withdrawn
- 2011-03-31 US US13/637,051 patent/US20130028920A1/en not_active Abandoned
- 2011-03-31 WO PCT/IB2011/051373 patent/WO2011121560A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013528570A5 (https=) | ||
| AU2017339418C1 (en) | Benzo[b]thiophene compounds as sting agonists | |
| JP6971239B2 (ja) | グルタミナーゼ阻害剤とイムノオンコロジー薬剤との併用療法 | |
| BR112020007536A2 (pt) | anticorpos anti-tau e seus usos | |
| KR102171669B1 (ko) | 조합물 및 이의 용도 | |
| BR112020003474A2 (pt) | composição farmacêutica, e, método para produzir uma composição farmacêutica | |
| RU2018119296A (ru) | Конъюгаты антитела, содержащие агонисты толл-подобного рецептора | |
| RU2016129894A (ru) | Ковалентно связанные конъюгаты хеликар-антитело против хеликара и их применения | |
| US20120128666A1 (en) | Methods of increasing neuronal differentiation using antibodies to lysophosphatidic acid | |
| TR201802093T4 (tr) | Terapötik terapilerde kullanım için akt inhibitör bileşiği ve abirateron kombinasyonu. | |
| JP2018076350A5 (https=) | ||
| JP2018502131A5 (https=) | ||
| JP2007522157A (ja) | 抗ｅｇｆｒ抗体の高濃縮液体製剤 | |
| CN114533880A (zh) | 用ezh2抑制剂治疗mrto/sccoht的方法 | |
| JP2011051993A5 (https=) | ||
| HRP20200032T1 (hr) | Antitijelo lijek konjugati | |
| WO2023186015A1 (zh) | B7h4抗体药物偶联物及其用途 | |
| JP6851989B2 (ja) | 医薬用共結晶及びその用途 | |
| UA123946C2 (uk) | Ацетамідтієнотриазолодіазепіни й шляхи їх застосування | |
| JP2013518036A5 (https=) | ||
| JP2017537886A5 (https=) | ||
| JP2010535198A (ja) | コハク酸のコリン塩を含む鼻腔内投与用医薬品組成物 | |
| MX2020002429A (es) | Compuestos para reducir la viscosidad de las formulaciones biologicas. | |
| AU2018251808A1 (en) | Stable anti-OSMR antibody formulation | |
| WO2022171121A1 (zh) | 治疗肿瘤的方法和组合 |